CanPharm: Your Comprehensive Pharmaceuticals Resource - Page 2

European Generic Markets: How Regulatory Approaches Across the EU Shape Drug Access and Competition

European Generic Markets: How Regulatory Approaches Across the EU Shape Drug Access and Competition

The EU's generic drug approval system is complex, with four different pathways, each affecting how quickly and where a generic reaches patients. The 2025 reforms have changed data protection, launch timelines, and supply rules-shifting how manufacturers enter the market.

Read More
How to Communicate Past Drug Reactions Before Surgery

How to Communicate Past Drug Reactions Before Surgery

Knowing how to clearly communicate past drug reactions before surgery can prevent life-threatening complications. Learn what counts as a true allergy, who needs to know, and how to ensure your history is properly documented for safe anesthesia.

Read More
Obesity as a Chronic Disease: Understanding Metabolic Health and Realistic Weight Strategies

Obesity as a Chronic Disease: Understanding Metabolic Health and Realistic Weight Strategies

Obesity is a chronic disease driven by biology, not choice. Learn how metabolic dysfunction, genetics, and modern treatments like GLP-1 agonists are changing how we manage weight - and why willpower alone doesn't work.

Read More
Packaging and Labeling: How to Verify the Authenticity of Generic Medicines

Packaging and Labeling: How to Verify the Authenticity of Generic Medicines

Learn how to spot fake generic medicines by checking packaging, using UV lights, scanning barcodes, and recognizing subtle differences. Real-world tips from pharmacists and experts to protect your health.

Read More
Generics vs Brand Biologics: How Much Do They Really Cost?

Generics vs Brand Biologics: How Much Do They Really Cost?

Biosimilars cut the cost of biologic drugs by over 50% on average, yet most patients still pay full price. Learn why the savings are real, why adoption is slow, and how you can access lower-cost alternatives.

Read More
RSV Infections: Risks for Infants, Older Adults, and How to Prevent Them

RSV Infections: Risks for Infants, Older Adults, and How to Prevent Them

RSV is the leading cause of hospitalization in infants and a major threat to older adults. Learn the real risks, how it spreads, and the new vaccines and preventions that are changing outcomes.

Read More
Using Copay Cards Safely: Access Without Compromising Care

Using Copay Cards Safely: Access Without Compromising Care

Copay cards help patients afford expensive medications-but hidden insurer policies like accumulator programs can leave you owing thousands when the card runs out. Learn how to protect your treatment and avoid dangerous financial surprises.

Read More
How to Appeal Insurance Denials for Brand-Name Medications

How to Appeal Insurance Denials for Brand-Name Medications

Learn how to successfully appeal insurance denials for brand-name medications with step-by-step guidance, real-world examples, and key documentation tips to get your prescription covered.

Read More
Generic Drug Quality Standards: FDA Requirements and Testing

Generic Drug Quality Standards: FDA Requirements and Testing

Generic drugs must meet the same strict quality, safety, and effectiveness standards as brand-name drugs. The FDA ensures this through rigorous testing, manufacturing oversight, and bioequivalence requirements - making generics safe, reliable, and affordable.

Read More
Supply Chain Problems: Distribution Risks for Generic Drugs

Supply Chain Problems: Distribution Risks for Generic Drugs

Generic drug shortages are at record levels due to thin profit margins, overreliance on overseas manufacturing, and lack of supply chain resilience. This affects patient care across the U.S., especially for critical injectables and older medications.

Read More
Recent Posts Tags Archive

© 2026. All rights reserved.